Navigation Links
ZeptoMetrix™ Corporation (ZMC) Announces the Release of Additional Zika Virus Culture Fluids
Date:5/17/2016

ZeptoMetrix™ Corporation (ZMC), announced today the release of 3 additional Zika Virus Strains to its product inventory to aid in the rapid development of diagnostic tests and for the manufacture of quality control reagents to monitor their effectiveness.

“We are offering as much support as possible to assist during this global Zika virus emergency”, explains Dr. Gregory R. Chiklis, President and CEO of ZeptoMetrix. “Our focus, has always been and will continue to be to support the diagnostics industry with as many precise, dependable and non-infectious tools as we can.”

To complement its currently expanding Tropical Disease Microorganism offerings (http://www.zeptometrix.com), ZeptoMetrix has introduced the following Zika Virus Culture Fluids to its product line:

Zika Virus (Strain: PRVABC59) Culture Fluid (1 mL) - # 0810525CF
Zika Virus (Strain: DakArD 41662) Culture Fluid (1 mL) - # 0810522CF
Zika Virus (Strain: MR 766) Culture Fluid (1 mL) - # 0810521CF

Using its proprietary NATtrol™ inactivation treatment, ZeptoMetrix has also released noninfectious, whole organism molecular quality controls and an assay range validation panel that can be used in clinical laboratories for daily test variation, lot-to-lot test kit performance, individual operator performance and assistance identifying trends in laboratory results.

NATtrol Zika Virus Range Verification Panel (4 x 0.5 mL) - # NATZIKV-RV
NATtrol Zika Virus, External Run Control, Medium (6 x 1 mL) - # NATZIKV-ERCM
NATtrol Zika Virus, External Run Control, Low (6 x 1 mL) - # NATZIKV-ERCL

Together, the routine and repetitive use of NATtrol™ External Run Controls and Range Verification Panels enables laboratories to verify test performance, track and monitor daily test variation, lot-to-lot test kit performance, individual operator performance to provide assistance identifying trends in laboratory results.

About ZeptoMetrix™:

ZeptoMetrix Corporation (ZMC) is a renowned industry leader and innovator identified with quality, reliable and trusted products and services for infectious disease diagnostic development. ZeptoMetrix is a fully integrated biotechnology company whose offerings support all phases of research & development, validation, manufacturing and commercialization of diagnostic testing.

Founded in 1999, ZeptoMetrix is headquartered in Buffalo, NY with additional facilities in Franklin, Massachusetts.

For Sales and/or information regarding Zika Virus Products, related Tropical Disease Products as well as other ZeptoMetrix Product Lines, please contact ZeptoMetrix Customer Relations directly.

Read the full story at http://www.prweb.com/releases/2016/05/prweb13416725.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. ZeptoMetrix™ (ZMC) to Release NATtrol™ Inactivated Zika Virus for the Development of Molecular Diagnostic Assays and Ongoing Clinical Laboratory Quality Control
2. Celsion Corporation to Hold First Quarter 2016 Financial Results Conference Call on Monday, May 16, 2016
3. United Therapeutics Corporation To Present At Deutsche Bank 41st Annual Health Care Conference
4. Seattle based non-profit, The Institute for Venture Science (IVS) today announced receipt of a significant operating grant from 1Plus12 Corporation.
5. Celsion Corporation Announces Enrollment of First Patient in the OPTIMA Study in China
6. United Therapeutics Corporation To Announce First Quarter 2016 Financial Results Before Market Open On Thursday, April 28, 2016
7. Cognition Corporation Releases Guided Template for PHA Compliance
8. Celsion Corporation Reports Year End 2015 Financial Results and Provides Business Update
9. Native Traits Corporation Announces the Launch of its EaSY (TM) Inbred Line Conversion Program
10. OHAUS Corporation Unveils New Laboratory Balances and Electrochemistry Meters At Pittcon 2016
11. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/18/2018)... (PRWEB) , ... December 18, 2018 , ... ... business process optimization firm for the life sciences industry, unveiled a completely redesigned ... while creating a more user-friendly browsing experience for their valued clients and business ...
(Date:12/13/2018)... ... December 11, 2018 , ... Researchers at Worcester ... to quickly detect Clostridium difficile (C. diff), a dangerous and sometimes fatal gastrointestinal ... that can be used onsite in doctor’s offices and nursing homes, providing results ...
(Date:12/13/2018)... ... 2018 , ... Microbial Discovery Group LLC (MDG) has expanded ... of their strategic plan and an important milestone in increasing their Bacillus fermentation ... MDG within the $44 Billion human probiotic market. This plan is a vital ...
(Date:12/5/2018)... ... December 05, 2018 , ... The incredible life story of ... in the European Parliament by Carlos Moedas, the European Commissioner for Research and Innovation. ... Innovation in Our Daily Lives, Commissioner Moedas spoke at length of Yousef’s life and ...
Breaking Biology Technology:
(Date:1/4/2019)... ... January 03, 2019 , ... ... cell culture models into their drug discovery research workflows with biology ranging from ... in vivo relevancy of in vitro studies, they create several challenges that need ...
(Date:12/27/2018)... ... December 27, 2018 , ... uBiome, the leader in microbial ... JP Morgan 37th Annual Healthcare Conference in San Francisco, which brings together industry ... community. , Since its origin in 1983, the JP Morgan Healthcare Conference ...
(Date:12/20/2018)... TRIANGLE PARK, N.C. (PRWEB) , ... December 20, ... ... have been enhanced through upgraded processes and the completion of a new usability/observation ... Evaluations with the goal of ensuring medical devices and drug delivery devices/combination products ...
Breaking Biology News(10 mins):